Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations.

Elise Pape Julien Scala-Bertola Nadine Petitpain Jean-Yves Jouzeau Sophie Charrois-Sciaudeau Véronique Kemmel Hélène Barraud Nicolas Gambier

Transplantation

1 Department of Clinical Pharmacology and Toxicology, CHU Nancy, Nancy, France. 2 Université de Lorraine, UMR 7365 CNRS-UL, IMoPA, Vandœuvre-lès-Nancy, France. 3 Pharmacovigilance Center of Lorraine, CHU Nancy, Nancy, France. 4 Department of Biochemistry, CHU Strasbourg, Strasbourg, France. 5 Department of Hepatology and Gastroenterology, CHU Nancy, Vandoeuvre-lès-Nancy, France.

Published: September 2015

Download full-text PDF	Source
http://dx.doi.org/10.1097/TP.0000000000000859	DOI Listing

Publication Analysis

Top Keywords

management tacrolimus-telaprevir

tacrolimus-telaprevir drug-drug

drug-drug interaction

interaction liver

liver transplant

transplant patient

patient hepatitis

hepatitis virus

virus practical

practical considerations

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!